$9,299.00
In Stock
Lemtrada or Campath a drug for the treatment of patients with relapsing multiple sclerosis, significantly reduces the frequency of relapses and slows the progression of physical disability.
The drug Lemtrada has a fundamentally new mechanism of action. It suppresses precisely those lymphocytes that can cause cell damage in MS, thereby reducing their levels.
Subsequently, the lymphocyte population is restored. After six months, the body produces new B cells, and after a year, T cells. This process regulates the immune system, thanks to which, among other things, the drug has a positive effect on the course of the disease.
For most patients, two courses of treatment are sufficient, after which the effect of the drug lasts for many years. Thus, the medicine “zeroes” the immune system and changes the course of the disease.
Active ingredient: alemtuzumab
Prescription medicine
